- Vouliez-vous dire
- vaccines effectiveness
Résultats de la recherche - 6 results
Effectiveness of XBB.1.5 Monovalent COVID-19 Vaccines During a Period of XBB.1.5 Dominance in EU/EEA Countries, October to November 2023: A VEBIS-EHR Network Study.
countries in the European Union/European Economic Area, we estimated XBB.1.5 monovalent vaccine effectiveness (VE) against COVID-19 hospitalisation and death in booster-eligible ≥ 65-year-olds, during ...
Relative vaccine effectiveness against COVID-19 hospitalisation in persons aged ≥ 65 years: results from a VEBIS network, Europe, October 2021 to July 2023.
COVID-19 Europe Hospitalization Humans Retrospective Studies Vaccine Efficacy Abstract: To monitor relative vaccine effectiveness (rVE) against COVID-19-related hospitalisation of the first, second and third ...
Couverture vaccinale et impact épidémiologique de la campagne de vaccination COVID-19 en Belgique. Données jusqu’au 31 octobre 2021 inclus
Wyndham-Thomas Source: Sciensano, Belgium, p.53 (2021) Accession Number: D/2021/14.440/79 Keywords: COVID-19 vaccination coverage vaccine impact Health Topics: Post-authorisation surveillance of COVID-19 vaccines ...
Vaccinatiegraad en epidemiologische impact van de COVID-19-vaccinatiecampagne in België. Gegevens tot en met 31 oktober 2021
Wyndham-Thomas Source: Sciensano, Belgium (2021) Accession Number: D/2021/14.440/80 Keywords: COVID-19 vaccination coverage vaccine impact Health Topics: Post-authorisation surveillance of COVID-19 vaccines ...
Vaccine effectiveness against infection and onwards transmission of COVID-19: Analysis of Belgian contact tracing data, January-June 2021.
Humans SARS-CoV-2 vaccines Abstract: In Belgium, high-risk contacts of an infected person were offered PCR-testing irrespective of their vaccination status. We estimated vaccine effectiveness (VE) against ...
Monovalent XBB.1.5 COVID-19 vaccine effectiveness against hospitalisations and deaths during the Omicron BA.2.86/JN.1 period among older adults in seven European countries: A VEBIS-EHR network study.
Hospitalization Humans Male SARS-CoV-2 Vaccination Vaccine Efficacy Abstract: BACKGROUND: We aimed to estimate XBB.1.5 vaccine effectiveness (VE) against COVID-19-related hospitalizations and deaths during BA.2.86/ ...